Product for T lymphocyte immunosuppression

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 6060054
SERIAL NO

08630172

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a product and process for suppressing an immune response using a T lymphocyte immunosuppression molecule capable of blocking cell surface molecules responsible for T cell activation. Disclosed is a CD4 or CD2 molecule, associated with an immunoglobulin molecule capable of binding to a major histocompatibility antigen. Also disclosed is a method to produce a T lymphocyte molecule, a therapeutic composition comprising a T lymphocyte immunosuppression molecule and methods to use T lymphocyte immunosuppression molecules in therapeutic processes requiring suppression of an immune response.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NATIONAL JEWISH CENTER FOR IMMUNOLOGY AND RESPIRATORY MEDICINE1400 JACKSON STREET DENVER CO 80206

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Staerz, Uwe D Denver, CO 17 122

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation